Avecho Biotechnology Limited (AVE.AX)
AUD 0.0
(0.0%)
AUD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 473.55 Thousand | 1.12 Million | 793.6 Thousand | 384.62 Thousand | 4.23 Million | 1.39 Million |
| Cost of Revenue | 517.34 Thousand | 336.14 Thousand | 1.58 Million | 2.1 Million | 1.85 Million | 553.32 Thousand |
| Gross Profit | -43.79 Thousand | 793.11 Thousand | -791.78 Thousand | -1.71 Million | 2.38 Million | 840.95 Thousand |
| Operating Expenses | 4.54 Million | 3.85 Million | 3.75 Million | 1.66 Million | 1.79 Million | 4.87 Million |
| Selling, General and Administrative Expenses | 2.42 Million | 2.26 Million | 1.62 Million | 1.48 Million | 1.63 Million | 3.98 Million |
| Research and Development Expenses | 2.11 Million | 1.59 Million | 2.13 Million | 187.6 Thousand | 166.04 Thousand | 1.03 Million |
| Other Expenses | - | 646.56 Thousand | 1.14 Million | 777.68 Thousand | 458.92 Thousand | -41.98 Thousand |
| Cost and Expenses | 5.06 Million | 4.19 Million | 5.34 Million | 3.77 Million | 3.65 Million | 5.42 Million |
| Operating Income | -4.58 Million | -3.06 Million | -4.55 Million | -3.38 Million | 587.32 Thousand | -4.97 Million |
| Interest Expense | 15.35 Thousand | 6349.00 | 9975.00 | 5925.00 | 11.03 Thousand | - |
| Income Tax Expense | -1.07 Million | -622.92 Thousand | -1.12 Million | -360.3 Thousand | -346 Thousand | -685.41 Thousand |
| Earnings before Tax | -4.51 Million | -2.96 Million | -4.54 Million | -2.99 Million | 503.94 Thousand | -3.99 Million |
| Net Income | -3.43 Million | -2.34 Million | -3.41 Million | -2.63 Million | 849.95 Thousand | -3.99 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
| Weighted Average Shares Outstanding | 2.26 Billion | 1.8 Billion | 1.8 Billion | 1.59 Billion | 1.57 Billion | 1.57 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.26 Billion | 1.83 Billion | 1.8 Billion | 1.59 Billion | 1.57 Billion | 1.57 Billion |
| Gross Margin | -0.09 | 0.70 | -1.00 | -4.47 | 0.56 | 0.60 |
| EBIT Margin | -6.85 | -1.86 | -5.19 | -7.41 | 0.30 | -3.05 |
| Profit Margin | -7.26 | -2.07 | -4.30 | -6.85 | 0.20 | -2.86 |
| EBITDA | -3.24 Million | -2.1 Million | -2.97 Million | -2.27 Million | 1.19 Million | -4.25 Million |
| Earnings Before Tax Margin | -9.69 | -2.71 | -5.73 | -8.81 | 0.14 | -3.57 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 312.18 Thousand | 27.11 Thousand | 473.55 Thousand | 446.43 Thousand | 371.02 Thousand | 1.12 Million |
| Cost of Revenue | 104.99 Thousand | 463.39 Thousand | 696.04 Thousand | 232.64 Thousand | 239.09 Thousand | 336.14 Thousand |
| Gross Profit | 207.19 Thousand | -436.28 Thousand | -222.49 Thousand | 213.79 Thousand | 131.92 Thousand | 793.11 Thousand |
| Operating Expenses | 3.1 Million | 1.63 Million | 4.36 Million | 2.73 Million | 2.11 Million | 3.85 Million |
| Selling, General and Administrative Expenses | 1.15 Million | 623.87 Thousand | - | 1.62 Million | 997.71 Thousand | - |
| Research and Development Expenses | 1.94 Million | 1 Million | - | 1.11 Million | 1.11 Million | - |
| Other Expenses | -1.08 Million | - | 1.13 Million | - | - | 646.56 Thousand |
| Cost and Expenses | 3.2 Million | 2.09 Million | 5.06 Million | 2.96 Million | 2.35 Million | 4.19 Million |
| Operating Income | -2.89 Million | -2.06 Million | -4.58 Million | -2.52 Million | -1.98 Million | -3.06 Million |
| Interest Expense | 5590.00 | 7787.00 | 15.35 Thousand | 7569.00 | 2688.00 | 6349.00 |
| Income Tax Expense | -523.73 Thousand | -695.58 Thousand | -1.07 Million | -379.98 Thousand | -368.89 Thousand | -622.92 Thousand |
| Earnings before Tax | -2.17 Million | -2 Million | -4.51 Million | -2.5 Million | -1.93 Million | -2.96 Million |
| Net Income | -2.17 Million | -1.3 Million | -3.43 Million | -2.12 Million | -1.56 Million | -2.34 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | - | -0.00 | -0.00 | - |
| Earnings Per Share Diluted | -0.00 | -0.00 | - | -0.00 | -0.00 | - |
| Weighted Average Shares Outstanding | 3.1 Billion | 3.16 Billion | 2.26 Billion | 1.93 Billion | 1.83 Billion | 1.8 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.16 Billion | 3.16 Billion | 2.26 Billion | 1.93 Billion | 1.83 Billion | 1.83 Billion |
| Gross Margin | 0.66 | -16.09 | -0.47 | 0.48 | 0.36 | 0.70 |
| EBIT Margin | -6.71 | -73.47 | - | -5.42 | -5.07 | - |
| Profit Margin | -6.97 | -48.28 | -7.26 | -4.77 | -4.22 | -2.07 |
| EBITDA | -2.09 Million | -1.99 Million | - | -2.41 Million | -1.87 Million | - |
| Earnings Before Tax Margin | -9.27 | -76.22 | -9.69 | -5.65 | -5.35 | -2.71 |
CENTA
FRPH
CS3
ADL
CGCL
CRSU